Navigation Links
Thoratec Announces Presentations At Upcoming Investor Conferences
Date:9/11/2012

PLEASANTON, Calif., Sept. 11, 2012 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in two upcoming investor conferences.

On Thursday, September 13, the company will participate in the ThinkEquity 9th Annual Growth Conference. Taylor C. Harris, Senior Director of Investor Relations and Business Development, will provide an update on the company beginning at 2:30 p.m., Eastern Daylight Time (11:30 a.m., Pacific Daylight Time). The presentation will be available through the conference web site at http://wsw.com/webcast/tep22/thor/, or on the company's web site at http://www.thoratec.com.

On Wednesday, September 19, Thoratec will participate in the UBS 2012 Global Life Sciences Conference. The presentation by Taylor C. Harris, Senior Director of Investor Relations and Business Development, will begin at 8:30 a.m., Eastern Daylight Time (5:30 a.m., Pacific Daylight Time). The presentation will be available through the conference web site at http://cc.talkpoint.com/ubsx001/091912a_im/?entity=55_7YKIS01, or on the company's web site at http://www.thoratec.com.

Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's products include the HeartMate® LVAS (Left Ventricular Assist System) and Thoratec® VAD (Ventricular Assist Device) with more than 20,000 devices implanted in patients suffering from heart failure. Thoratec also manufactures and distributes the CentriMag® and PediMag®/PediVAS® product lines. Thoratec is headquar
'/>"/>

SOURCE Thoratec Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Thoratec Schedules First Quarter Conference Call, Webcast
2. Thoratec Reports First Quarter 2012 Results
3. Thoratec Schedules Second Quarter Conference Call, Webcast
4. Thoratec Reports Second Quarter Results
5. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
6. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
7. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
8. Misonix Announces New Distribution Agreement For Panama
9. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
10. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
11. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... JERUSALEM , Feb. 27, 2015  Chiasma, ... its lead product for the orphan condition acromegaly, today ... financing round. Participants in the financing included new investors ... blue chip public investment fund, as well as existing ... Abingworth and ARCH Venture Partners. Chiasma ...
(Date:2/26/2015)... DALLAS , February 27, 2015 ... Review, H2 2014 market research report to its ... the Corneal Ulcers, therapeutic pipeline. The ... information on the therapeutic development for Corneal Ulcers. ... infections that includes bacterial infections, viral infections & ...
(Date:2/26/2015)... Ill. , Feb. 26, 2015  Today the ... The psychological and physical side effects of ... that opioid painkillers, such as Vicodin and Oxycontin, are ... "More Americans overdose on prescription painkillers than on heroin ... president and CEO of NSC. "Yet, these medications are ...
Breaking Medicine Technology:Chiasma Announces Completion of $70 Million Series E Financing 2Chiasma Announces Completion of $70 Million Series E Financing 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5National Safety Council: Opioid prescription painkillers have hidden, deadly side effects 2
... HOERSHOLM, Denmark and SAN DIEGO, California, October 28 ... Wedel, MD, FACP Joins as Vice President and Chief,Medical Officer ... - Stuart Mackey, JD joins as ... Development for Proprietary RNA-targeted,Locked Nucleic Acid (LNA) Drug Platform , ...
... Incorporated (Nasdaq: VPHM ) reported today its financial results for ... million in net product sales including $29 million in net sales ... net income reached $20 million; Improved working capital to $358 ... including cash and cash equivalents of $289 million; and ...
Cached Medicine Technology:Santaris Pharma A/S Expands Executive Team, Appoints Chief Medical Officer and Chief Business Officer to Advance Proprietary RNA-targeted Drug Development Programs 2Santaris Pharma A/S Expands Executive Team, Appoints Chief Medical Officer and Chief Business Officer to Advance Proprietary RNA-targeted Drug Development Programs 3Santaris Pharma A/S Expands Executive Team, Appoints Chief Medical Officer and Chief Business Officer to Advance Proprietary RNA-targeted Drug Development Programs 4ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 2ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 3ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 4ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 5ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 6ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 7ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 8ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 9ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 10ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 11ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 12ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 13ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 14ViroPharma Incorporated Reports Third Quarter 2009 Financial Results 15
(Date:2/27/2015)... February 27, 2015 Hispanics develop alcoholic ... between four and 12 years earlier than Whites/Caucasians or ... Davis Health System. , While previous research indicated that ... populations, the new study -- published online in the ... to be the first to pinpoint racial and ethnic ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 OnChip ... (IPD), has introduced miniature, wire bondable, silicon ESD (Electrostatic ... LED markets. The ESD88NP and ... away from sensitive LED and IC products. These ... Varistors (MLV). All devices meet the requirements of ...
(Date:2/27/2015)... 27, 2015 Just a little over ... those suffering from Sjögren’s Syndrome after a new autoantibody ... at the University of Buffalo and Immco Diagnostics, Inc. ... was to develop a new diagnostic test ... of new autoantibodies. Researchers aimed to develop a test ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Today, February 27th, ... KAJ Brothers , along with LXR Organics and ... END IT Campaign to raise awareness and promote prevention, rescue ... statistics provided by the END IT Coalition, slavery is the ... year and exists in 167 countries around the world. Slavery ...
(Date:2/27/2015)... CA (PRWEB) February 27, 2015 Clinovo, ... ClinCapture, its validated Electronic Data Capture (EDC) at the ... California on March 2nd and March 3rd at Booth ... self-service platform and DIY CRF and edit-check builder allowing ... in a matter of days, without any programming experience. ...
Breaking Medicine News(10 mins):Health News:UC Davis Study Finds Hispanics Develop Alcoholic Liver Disease at Younger Ages than Caucasians or African Americans 2Health News:OnChip Introduces New Series of Space Saving Bare-die Zener Diodes for Transient Voltage Suppression 2Health News:OnChip Introduces New Series of Space Saving Bare-die Zener Diodes for Transient Voltage Suppression 3Health News:Breakthrough Blood Test for Early Detection of Sjögren’s Syndrome Now Available 2Health News:KAJ Brothers Join the Campaign to 'End It - Shine A Light On Slavery' 2Health News:Clinovo to Demo Its Self-Service, Cloud-Based EDC Solution at CALBIO2015 on March 2nd and 3rd, 2015 2
... had published a report on a new way to detect ... Harvard Mental Health Letter, tests of // cognitive function are ... people will develop Alzheimer’s. In one study, more than 80% ... test of delayed word recall developed Alzheimer’s over the next ...
... hospitals, a small increase in the malfunction of the ... especially for patients suffering from acute kidney injury (AKI). ... reported these results in the latest issue of the ... researchers had analyzed data on 9,210 hospitalized patients who ...
... undergoing a revolution with increasing importance being given to ... of resources allocated to research in specific genetic disorders. ... to scientists working in the field of genetics but ... acquired new. One such breakthrough has been the successful ...
... for children who suffer from chronic sinusitis only ... suggests that life after surgery for these children ... is the first-line surgical therapy for chronic rhinosinusitis ... also being performed with increased frequency to treat ...
... Cornell University in New York are under investigation for ... false information on protocols with the US National Institutes ... a university research center. , ,Former researcher at ... the clinic to treat her adult patient’s and alleged ...
... is a wrinkle control cream and a potent neurotoxin, ... The product is derived form a bacteria, Clostridium botulinum, ... to note that this form of neurotoxin is playing ... cells. The research is exploring basic nerve cell function, ...
Cached Medicine News:
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: